Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

被引:252
作者
Styczynski, J. [2 ]
Reusser, P. [3 ,10 ]
Einsele, H. [4 ]
de la Camara, R. [5 ]
Cordonnier, C. [6 ,7 ]
Ward, K. N. [8 ]
Ljungman, P. [9 ]
Engelhard, D. [1 ]
机构
[1] Hebrew Univ Jerusalem, Hadassah Univ Hosp, Dept Pediat, IL-91120 Jerusalem, Israel
[2] Coll Med UMK, Dept Pediat Hematol & Oncol, Bydgoszcz, Poland
[3] Hop Jura, Dept Med, Porrentruy, Switzerland
[4] Wuerzburg Univ Hosp, Dept Internal Med, Wurzburg, Germany
[5] Hosp Princesa, Serv Hematol, Madrid, Spain
[6] Henri Mondor Teaching Hosp, AP HP, Dept Hematol, Creteil, France
[7] Univ Paris 12, Creteil, France
[8] UCL, Ctr Virol, London, England
[9] Karolinska Univ, Dept Hematol, Huddinge Hosp, Stockholm, Sweden
[10] Univ Basel, Sch Med, Basel, Switzerland
关键词
leukemia; SCT; HSV; VZV; EBV; guidelines; VARICELLA-ZOSTER-VIRUS; HERPES-SIMPLEX-VIRUS; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; HIGH-DOSE CHEMOTHERAPY; LONG-TERM ACYCLOVIR; SEVERELY IMMUNOCOMPROMISED PATIENTS; ANTI-CD20; MONOCLONAL-ANTIBODY; CORD BLOOD TRANSPLANTATION;
D O I
10.1038/bmt.2008.386
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
These guidelines on the management of HSV, VZV and EBV infection in patients with hematological malignancies and after SCT were prepared by the European Conference on Infections in Leukemia following a predefined methodology. A PubMed search was conducted using the appropriate key words to identify studies pertinent to management of HSV, VZV and EBV infections. References of relevant articles and abstracts from recent hematology and SCT scientific meetings were also reviewed. Prospective and retrospective studies identified from the data sources were evaluated, and all data deemed relevant were included in this analysis. The clinical and scientific background was described and discussed, and the quality of evidence and level of recommendation were graded according to the Centers for Disease Control criteria. Bone Marrow Transplantation (2009) 43, 757-770; doi:10.1038/bmt.2008.386; published online 1 December 2008
引用
收藏
页码:757 / 770
页数:14
相关论文
共 176 条
[1]   Varicella-zoster virus: Pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients [J].
Arvin, AM .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (03) :219-230
[2]  
ASANO Y, 1993, PEDIATRICS, V92, P219
[3]  
ATKINSON K, 1982, BLOOD, V60, P714
[4]   VARICELLA-ZOSTER VIRUS-INFECTION AFTER MARROW TRANSPLANTATION FOR APLASTIC-ANEMIA OR LEUKEMIA [J].
ATKINSON, K ;
MEYERS, JD ;
STORB, R ;
PRENTICE, RL ;
THOMAS, ED .
TRANSPLANTATION, 1980, 29 (01) :47-50
[5]   Disseminated zoster, hyponatraemia, severe abdominal pain and leukaemia relapse: recognition of a new clinical quartet after bone marrow transplantation [J].
Au, WY ;
Ma, SY ;
Cheng, VCC ;
Ooi, CGC ;
Lie, AKW .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (04) :862-865
[6]   ACYCLOVIR THERAPY OF VARICELLA-ZOSTER VIRUS-INFECTIONS IN IMMUNOCOMPROMISED PATIENTS [J].
BALFOUR, HH ;
MCMONIGAL, KA ;
BEAN, B .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 :169-179
[7]   ACYCLOVIR HALTS PROGRESSION OF HERPES-ZOSTER IN IMMUNOCOMPROMISED PATIENTS [J].
BALFOUR, HH ;
BEAN, B ;
LASKIN, OL ;
AMBINDER, RF ;
MEYERS, JD ;
WADE, JC ;
ZAIA, JA ;
AEPPLI, D ;
KIRK, LE ;
SEGRETI, AC ;
KEENEY, RE .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (24) :1448-1453
[8]   Antiviral drugs [J].
Balfour, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (16) :1255-1268
[9]  
BALLEN KK, 1992, TRANSPLANTATION, V54, P553
[10]   ACYCLOVIR GIVEN AS PROPHYLAXIS AGAINST ORAL ULCERS IN ACUTE MYELOID-LEUKEMIA - RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
BERGMANN, OJ ;
ELLERMANNERIKSEN, S ;
MOGENSEN, SC ;
ELLEGAARD, J .
BMJ-BRITISH MEDICAL JOURNAL, 1995, 310 (6988) :1169-1172